Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Blood Glucose Monitoring System LS-9 of Leison Biotech Co., Ltd. in Accordance With DIN EN ISO 15197:2015

NCT07353125 is registered in ClinicalTrials.gov with Institut fur Diabetes Karlsburg GmbH as lead sponsor.

NCT NCT07353125
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07353125 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Blood Glucose Monitoring System LS-9 of Leison Biotech Co., Ltd. in Accordance With DIN EN ISO 15197:2015
Lead sponsor
Institut fur Diabetes Karlsburg GmbH
Phase
Not applicable
Overall status
Completed
Start date
July 21, 2025
Completion date
September 22, 2025
Enrollment
219 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes